ArticleFrontiers in oncology2020

Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors.

Donjete Simnica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.